#AnestIwata

At the 80th Annual General Meeting of Shareholders scheduled for June 26, 2026, resolutions will be made regarding the appointment of candidates for directors and Audit and Supervisory Committee members. Mr. Kazuhisa Fujita is scheduled to be appointed as a new Outside Director candidate.

For the cumulative third quarter of FY March 2026, net sales were 39,488 million yen (YoY △1.3%), operating income was 3,796 million yen (YoY △18.1%), and net income attributable to owners of the parent was 3,376 million yen (YoY △5.6%).

3Q FY2026 sales were JPY 39,488 million (YoY -1.3%), operating income was JPY 3,796 million (YoY -18.1%), and the full-year earnings forecast remains unchanged.